In an extraordinary display of dedication, heart, and hoop talent, sisters Sophie and Emma Zirkin—2 standout high school basketball players from Maryland—turned their grief into action by shooting 10,000 3-pointers to raise funds for lung cancer [...]
When Dr. Bryant Lin noticed a persistent cough and an unusual tightness in his throat last spring, he didn’t panic. A busy primary care doctor, clinical professor at Stanford Medicine, and co-director of Stanford’s Center for Asian Health Research [...]
Lung cancer remains the leading cause of cancer deaths in every state, nationwide. In 2025, it is estimated that more people will die from lung cancer than from breast and colorectal cancers combined. Despite this fact, lung cancer continues [...]
To honor Women’s Health Month, we sat down with Narjust Florez, MD, to discuss how lung cancer uniquely affects women. Research shows that women often face different—and sometimes more severe—experiences with lung cancer than men. These differences happen because [...]
New members bring bold leadership and lived experience to accelerate progress for the lung cancer community GO2 for Lung Cancer (GO2) proudly announces the appointment of two new members to its Board of Directors: Margaret Richardson, chief corporate affairs [...]
Did you know? There are different kinds of changes, called mutations, that can happen in the MET gene. These changes can help cancer grow and spread. One type is called c-MET overexpression. This means the cancer cells make too [...]
A statement from GO2 for Lung Cancer’s President and CEO Laurie Ambrose on the proposed federal budget cuts The President recently submitted a Fiscal Year 2026 budget request that proposes yet again deep cuts to and elimination of key [...]
WASHINGTON, May 1, 2025 – As the nation recognizes May as Women’s Health Month, GO2 for Lung Cancer (GO2) is proud to celebrate a milestone: the Women and Lung Cancer Research and Preventive Services Act of 2025 (H.R. 2319) [...]
GO2 for Lung Cancer remains at the forefront of leading advocacy efforts to restore funding for the Lung Cancer Research Program. In preparation for today’s Senate Appropriations Committee hearing, “Biomedical Research: Keeping America’s Edge in Innovation,” we submitted written [...]
Author: Matthew Reiss, MSE, PhD, Manager, Precision Medicine & Navigation, GO2 for Lung Cancer Question: Why does it take so long for the FDA to approve new drugs? Answer: Whenever a new cancer drug is created, it [...]